Organon has reported data from a post hoc analysis of pooled data from its Phase III ADORING 1 and ADORING 2 atopic dermatitis trials of Vtama cream, 1%.

The post Organon reports new findings from Vtama atopic dermatitis trials appeared first on Clinical Trials Arena.